Daniel C Cattran
Overview
Explore the profile of Daniel C Cattran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
6053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbour S, Coppo R, Er L, Russo M, Liu Z, Ding J, et al.
Kidney Int
. 2024 Aug;
106(5):913-927.
PMID: 39094695
The pediatric International IgA Nephropathy (IgAN) Prediction Tool comprises two models with and without ethnicity and is the first method to predict the risk of a 30% decline in estimated...
2.
Kadatz M, Klarenbach S, So H, Fervenza F, Cattran D, Barbour S
Nephrol Dial Transplant
. 2024 Apr;
39(12):2058-2066.
PMID: 38621719
Background And Hypothesis: The MENTOR trial (MEmbranous Nephropathy Trial Of Rituximab) showed that rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria and was superior in...
3.
Cattran D, Floege J, Coppo R
Kidney Int Rep
. 2023 Dec;
8(12):2515-2528.
PMID: 38106572
The highly variable rate of decline in kidney function in patients with immunoglobulin A nephropathy (IgAN) provides a major clinical challenge. Predicting which patients will progress to kidney failure, and...
4.
Troyanov S, Jauhal A, Reich H, Hladunewich M, Cattran D
Kidney Int Rep
. 2023 Nov;
8(11):2403-2415.
PMID: 38025232
Introduction: Kidney outcomes are improved in primary focal segmental glomerulosclerosis (FSGS) by maintaining a remission in proteinuria. However, characteristics associated with relapses are uncertain. We sought to identify these by...
5.
Sethi S, Beck Jr L, Glassock R, Haas M, De Vriese A, Caza T, et al.
Mayo Clin Proc
. 2023 Oct;
98(11):1671-1684.
PMID: 37804268
Membranous nephropathy (MN) is a pattern of injury caused by autoantibodies binding to specific target antigens, with accumulation of immune complexes along the subepithelial region of glomerular basement membranes. The...
6.
Sethi S, Beck Jr L, Glassock R, Haas M, De Vriese A, Caza T, et al.
Kidney Int
. 2023 Oct;
104(6):1092-1102.
PMID: 37795587
Membranous nephropathy (MN) is a pattern of injury caused by autoantibodies binding to specific target antigens, with accumulation of immune complexes along the subepithelial region of glomerular basement membranes. The...
7.
Barbour S, Fervenza F, Induruwage D, Brenchley P, Rovin B, Hladunewich M, et al.
Clin J Am Soc Nephrol
. 2023 Jul;
18(10):1283-1293.
PMID: 37471101
Background: The 2021 Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend following anti-phospholipase A2 receptor (PLA2R) antibody levels as a marker of treatment response in membranous nephropathy; however, the optimal...
8.
Kiryluk K, Sanchez-Rodriguez E, Zhou X, Zanoni F, Liu L, Mladkova N, et al.
Nat Genet
. 2023 Jun;
55(7):1091-1105.
PMID: 37337107
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-diagnosed IgAN cases and 28,751...
9.
Mariani L, Eddy S, Alakwaa F, McCown P, Harder J, Nair V, et al.
Kidney Int
. 2022 Nov;
103(3):565-579.
PMID: 36442540
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, there are variable rates of progression...
10.
Jauhal A, Reich H, Hladunewich M, Barua M, Hansen B, Naimark D, et al.
Nephrol Dial Transplant
. 2022 Aug;
38(4):950-960.
PMID: 35948275
Background: Although the clinical benefit of obtaining a remission in proteinuria in nephrotic patients with focal segmental glomerulosclerosis (FSGS) is recognized, the long-term value of maintaining it and the impact...